Lepu Medical Technology (Beijing) Co., Ltd. (SHE:300003)

SHE:300003 Income Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Jan 1, 2022	Dec 31, 2020	Dec 31, 2019
Operating Revenue	6,442	7,916	10,553	10,613	7,992	7,759
Other Revenue	64.24	64.24	56.93	46.74	46.61	36.29
Revenue	6,506	7,980	10,609	10,660	8,039	7,796
Revenue Growth (YoY)	-28.56%	-24.78%	-0.47%	32.61%	3.12%	22.64%
Cost of Revenue	2,578	2,982	4,021	4,166	2,660	2,171
Gross Profit	3,928	4,998	6,588	6,494	5,378	5,624
Selling, General & Admin	2,132	2,440	2,776	2,858	2,445	2,758
Research & Development	761.64	879.42	957.06	907.94	736.13	543.91
Other Operating Expenses	59.92	58.37	33.9	103.14	82.56	91.58
Operating Expenses	2,979	3,404	3,793	3,882	3,303	3,427
Operating Income	949.41	1,594	2,795	2,612	2,076	2,197
Interest Expense	-174.33	-170.65	-188.78	-228.49	-268.92	-321.7
Interest & Investment Income	110.83	115.34	87.99	57.59	43.16	239.41
Currency Exchange Gain (Loss)	-25.38	-25.38	16.14	6.58	-26.96	6.82
Other Non Operating Income (Expenses)	-40.1	-7.99	-25.77	-79.03	-23.96	-151.18
EBT Excluding Unusual Items	820.43	1,505	2,684	2,368	1,799	1,970
Impairment of Goodwill	-33.45	-33.45	-	-	-	-108.04
Gain (Loss) on Sale of Investments	0.56	-13.44	-70.91	-367.54	298.06	106.6
Gain (Loss) on Sale of Assets	9.78	-4.07	0.02	19.9	2.29	4.12
Asset Writedown	-20.12	-6.93	-1.72	-2.39	-16.99	-36.87
Other Unusual Items	107.31	107.31	-	127.71	121.03	127.17
Pretax Income	884.52	1,554	2,612	2,146	2,203	2,063
Income Tax Expense	212.04	262.15	365.73	365.73	326.23	339.46
Earnings From Continuing Operations	672.47	1,292	2,246	1,780	1,877	1,724
Minority Interest in Earnings	34.78	-34.15	-42.28	-61.09	-75.15	1.51
Net Income	707.26	1,258	2,204	1,719	1,802	1,725
Net Income to Common	707.26	1,258	2,204	1,719	1,802	1,725
Net Income Growth	-59.52%	-42.91%	28.18%	-4.58%	4.44%	41.57%
Shares Outstanding (Basic)	1,853	1,862	1,802	1,792	1,777	1,770
Shares Outstanding (Diluted)	1,853	1,862	1,817	1,808	1,777	1,770
Shares Change (YoY)	-0.67%	2.48%	0.50%	1.75%	0.37%	-0.64%
EPS (Basic)	0.38	0.68	1.22	0.96	1.01	0.97
EPS (Diluted)	0.38	0.68	1.21	0.95	1.01	0.97
EPS Growth	-59.25%	-44.29%	27.54%	-6.22%	4.05%	42.49%
Free Cash Flow	158.97	145.69	1,885	2,078	1,490	1,427
Free Cash Flow Per Share	0.09	0.08	1.04	1.15	0.84	0.81
Dividend Per Share	0.473	0.331	0.341	0.275	0.228	0.200
Dividend Growth	38.83%	-2.81%	24.00%	20.61%	14.00%	21.21%
Gross Margin	60.38%	62.63%	62.10%	60.92%	66.90%	72.15%
Operating Margin	14.59%	19.97%	26.34%	24.50%	25.82%	28.18%
Profit Margin	10.87%	15.77%	20.77%	16.13%	22.42%	22.13%
Free Cash Flow Margin	2.44%	1.83%	17.77%	19.49%	18.53%	18.31%
EBITDA	1,424	2,040	3,205	3,004	2,464	2,481
EBITDA Margin	21.88%	25.57%	30.21%	28.18%	30.65%	31.83%
D&A For EBITDA	474.24	446.75	410.11	392.37	388.21	284.49
EBIT	949.41	1,594	2,795	2,612	2,076	2,197
EBIT Margin	14.59%	19.97%	26.34%	24.50%	25.82%	28.18%
Effective Tax Rate	23.97%	16.86%	14.00%	17.04%	14.81%	16.45%
Revenue as Reported	6,506	7,980	10,609	10,660	8,039	7,796
Advertising Expenses	-	84.23	60.08	76.04	76.08	66.14

Source: S&P Capital IQ. Standard template. Financial Sources.